Pulmatrix, Inc. (PULM)
1.56
+0.16
(+11.83%)
USD |
NASDAQ |
Sep 09, 12:07
Pulmatrix Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.0018 |
| March 31, 2024 | 0.4528 |
| December 31, 2023 | 0.4866 |
| September 30, 2023 | 0.4336 |
| June 30, 2023 | 0.0153 |
| March 31, 2023 | 0.0288 |
| December 31, 2022 | 0.0275 |
| September 30, 2022 | 0.0366 |
| June 30, 2022 | 0.0443 |
| March 31, 2022 | 0.0467 |
| December 31, 2021 | 0.0482 |
| September 30, 2021 | 0.0199 |
| June 30, 2021 | 0.0223 |
| March 31, 2021 | 0.0259 |
| December 31, 2020 | 0.0753 |
| September 30, 2020 | 0.0806 |
| June 30, 2020 | 0.1473 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0737 |
| December 31, 2019 | 0.0613 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.3353 |
| December 31, 2017 | 0.3177 |
| September 30, 2017 | 0.3049 |
| June 30, 2017 | 0.2881 |
| March 31, 2017 | 0.3259 |
| December 31, 2016 | 0.6624 |
| September 30, 2016 | 0.3666 |
| June 30, 2016 | 0.3365 |
| March 31, 2016 | 0.2397 |
| December 31, 2015 | 0.2061 |
| September 30, 2015 | 0.1876 |
| June 30, 2015 | 0.1706 |
| March 31, 2015 | -0.9763 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.246M |
| Total Liabilities (Quarterly) | 0.689M |
| Shareholders Equity (Quarterly) | 2.557M |
| Current Ratio | 4.701 |